A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial.
To discuss this further with Claire was the Head of Research with the Irish Cancer Society Dr Claire Kilty and UPMC Professor of Cancer Clinical Trials and a Consultant in Medical Oncology Anna Olsson-Brown.
